Rather than spending resources on "propping and buying" to artificially keep the price at a certain level , maybe the muscleheads should focus those resources on becoming "cash flow positive and profitable."
That was my original point, but only propping on the part of someone who is making up the difference each day whatever that needs to be in order to close above $4.
It would need less propping if they could release a positive PR of some sort.
Maybe they have assurances ahead of time of institutional buying once they get listed on a higher exchange in which case we are moved down from 2nd Class investors to 3rd Class in their scheme of importance.
No need for PR's until AFTER institutional investors are on board.
That way, the institutions will get a nice boost in the pps AFTER they get in.
How many institutions aren't allowed to buy Muscle Pharm until it is offered on a larger exchange?
News 
Market Data 
Discover 
